Severity of Clostridium difficile–Associated Disease (CDAD) in Allogeneic Stem Cell Transplant Recipients: Evaluation of a CDAD Severity Grading System
- 1 February 2007
- journal article
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 28 (2) , 208-211
- https://doi.org/10.1086/511792
Abstract
The purpose of this study was to develop and test a Clostridium difficile-associated disease (CDAD) grading system based on presenting symptoms in allogeneic stem cell transplant recipients. Patients with severe CDAD had significantly shorter median survival times and more adverse outcomes than patients with mild or moderate CDAD.Keywords
This publication has 19 references indexed in Scilit:
- Clostridium difficile colitis causing toxic megacolon, severe sepsis and multiple organ dysfunction syndromeIntensive Care Medicine, 2003
- Rarity of toxigenic Clostridium difficile infections after hematopoietic stem cell transplantation: implications for symptomatic management of diarrheaBone Marrow Transplantation, 2002
- Clostridium difficileInfection in Patients with NeutropeniaClinical Infectious Diseases, 2001
- Infectious gastro-enteritis: an uncommon cause of diarrhoea in adult allogeneic and autologous stem cell transplant recipientsBone Marrow Transplantation, 2000
- Clostridium difficile -associated diseasesIntensive Care Medicine, 2000
- Pseudomembraneous clostridium after autologous bone marrow transplantationBone Marrow Transplantation, 1998
- Clostridium difficile infection as a cause of severe sepsisIntensive Care Medicine, 1996
- Clostridium difficile causing sepsis and an acute abdomen in critically ill patientsCritical Care Medicine, 1995
- Severe Clostridium difficile colitisDiseases of the Colon & Rectum, 1995
- CDC definitions for nosocomial infections, 1988American Journal of Infection Control, 1988